Profil
Stephen Dale worked as the Global Clinical VP & Clinical Head-Oncology at AstraZeneca PLC from 2006 to 2015.
He then served as the Senior VP & Global Head-Medical Science at Kyowa Kirin Ltd. from 2018 to 2020.
Currently, he is the Chief Medical Officer at Kura Oncology, Inc. since 2020.
Dr. Dale obtained a doctorate degree from Manchester Medical School.
Anciens postes connus de Stephen Dale
| Sociétés | Poste | Fin |
|---|---|---|
| KURA ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | 02/01/2025 |
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 01/08/2020 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/09/2015 |
Formation de Stephen Dale
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kura Oncology, Inc.
Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Health Technology |
Manchester Medical School
Manchester Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















